- New derivatives of 7-chloroquinolin-4-amine with antiprotozoal activity
-
Novel ω-aminoacyl and -alkyl derivatives of 7-chloroquinolin-4-amine were prepared and their structures confirmed by NMR spectroscopy. Their antiprotozoal activities were examined in vitro against the sensitive NF54 strain as well as against the multiresistant K1strain of Plasmodium falciparum and against Trypanosoma brucei rhodesiense (STIB 900). The results were compared with the activities of clinically used drugs. Their antitrypanosomal activities were only moderate whereas their antiplasmodial activities looked very promising. Some were equal or slightly more active than chloroquine against the sensitive strain. However, in comparison to chloroquine, the activity of the new compounds was decreased much less in the resistant strain. Several possessed activity against both strains in low nanomolar concentration.
- Faist, Johanna,Hinteregger, Clemens,Seebacher, Werner,Saf, Robert,M?ser, Pascal,Kaiser, Marcel,Weis, Robert
-
-
Read Online
- Design, Synthesis, and Cytotoxic Evaluation of Certain 7-Chloro-4-(piperazin-1-yl)quinoline Derivatives as VEGFR-II Inhibitors
-
Signaling pathway inhibition of VEGFR-II is visualized as valuable tool in cancer management. In the current study, the synthesis of novel 1-4-(7-chloroquinolin-4-yl)piperazin-1-yl)-2-(N-substituted-amino)-ethanone derivatives (4a–t) was achieved through the amination of 2-chloro-1-(4-(7-chloroquinolin-4-yl)piperazin-1-yl)ethanone (3) with different secondary amines. The structures of the target compounds were confirmed by IR, 1H-NMR, 13C-NMR, HRMS, and microanalysis. Compounds 4a–t were subjected to in vitro anticancer screening against human breast cancer (MCF-7) and prostate cancer (PC3) cell lines. The highest cytotoxicty against both cell lines was displayed by 2-(4-(4-bromobenzyl)piperazin-1-yl)-1-(4-(7-chloroquinolin-4-yl)piperazin-1-yl)ethanone (4q), with IC50 values of 6.502 and 11.751 μM against MCF-7 and PC3 cells, respectively, compared with the standard drug doxorubicin (MCF-7: 6.774 μM, PC3: 7.7316 μM). Due to its notable activity toward MCF-7 cells, 4q was further evaluated as VEGFR-II inhibitor, showing an IC50 of 1.38 μM compared to sorafenib (0.33 μM). The docking study proved that 4q has a binding mode akin to that of VEGFR-II inhibitors.
- Aboul-Enein, Mohamed Nabil,El-Azzouny, Aida M. Abd El-Sattar,Ragab, Fatma Abdel-Fattah,Hamissa, Mohamed Farouk
-
-
Read Online
- Antiparasitic Agents: Part VI-Synthesis of 7-Chloro-4-(4-substituted-phenylamino)- and 7-Chloro-4-(4-substituted-piperazin-1-yl)quinolines as Potential Antiparasitic Agents
-
The synthesis of a series of 7-chloro-4-(4-hydroxy-3-substituted-phenylamino)quinolines (9-13, 31-40, 58) and 7-chloro-4-(4-substituted-piperazin-1-yl)quinolines (41-51, 53-55) has been carried out.These compounds have been tested for their antimalarial,
- Agrawal, Vijai K.,Sharma, Satyavan
-
p. 550 - 555
(2007/10/02)
-